Wang, Feng
Qin, Shukui
Sun, Xinchen
Ren, Zhenggang
Meng, Zhiqiang
Chen, Zhendong
Chai, Xiaoli
Xiong, Jianping
Bai, Yuxian
Yang, Lin
Zhu, Hong
Fang, Weijia
Lin, Xiaoyan
Chen, Xiaoming
Li, Enxiao
Wang, Linna
Yan, Ping
Zou, Jianjun
Funding for this research was provided by:
Jiangsu Hengrui Medicine Co. Ltd (NA)
Article History
Received: 24 February 2020
Accepted: 28 April 2020
First Online: 11 May 2020
Ethics approval and consent to participate
: The protocol of the phase 2 study was reviewed and approved by the Ethics Committee of each study site. The study was conducted in compliance with the ethical principles of Good Clinical Practice and the requirements of local laws and regulations, as well as the Declaration of Helsinki and its amendments. Written informed consent was obtained from each patient.
: Not applicable
: Linna Wang, Ping Yan, and Jianjun Zou are employees of Jiangsu Hengrui Medicine Co., Ltd. Other co-authors declare no competing interests.